Per-Ola Carlsson
Overview
Explore the profile of Per-Ola Carlsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
2860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlsson P, Espes D, Sisay S, Davies L, Smith C, Svahn M
Diabetologia
. 2025 Feb;
PMID: 39998647
No abstract available.
2.
Wernroth M, Kennedy B, Fall K, Nguyen D, Smew A, Carlsson P, et al.
Diabetologia
. 2024 Dec;
68(3):549-556.
PMID: 39694913
Aims/hypothesis: The potential impact of childhood bereavement-a severe psychological stressor-on childhood type 1 diabetes development remains unclear. Here, we aimed to bridge this knowledge gap and assess whether bereavement characteristics...
3.
Dawnbringer J, Hill H, Lundgren M, Catrina S, Caballero-Corbalan J, Cederblad L, et al.
BMJ Open Diabetes Res Care
. 2024 Sep;
12(4).
PMID: 39242123
Introduction: Despite the improvements in diabetes management by continuous glucose monitoring (CGM) it is difficult to capture the complexity of CGM data in one metric. We aimed to develop a...
4.
Jin Z, Hammoud H, Bhandage A, Korol S, Trujeque-Ramos O, Koreli S, et al.
EBioMedicine
. 2024 Jun;
105:105217.
PMID: 38943728
Background: γ-aminobutyric acid (GABA), known as the main inhibitory neurotransmitter in the brain, exerts immunomodulatory functions by interaction with immune cells, including T cells. Metabolic programs of T cells are...
5.
Thorngren J, Brboric A, Vasylovska S, Hjelmqvist D, Westermark G, Saarimaki-Vire J, et al.
Diabetes
. 2024 Apr;
73(7):1127-1139.
PMID: 38603470
Article Highlights:
6.
Lundkvist P, Gronberg A, Carlsson P, Ludvigsson J, Espes D
BMJ Open Diabetes Res Care
. 2024 Feb;
12(1).
PMID: 38413173
Introduction: The rate of progression to complete insulin deficiency varies greatly in type 1 diabetes. This constitutes a challenge, especially when randomizing patients in intervention trials aiming to preserve beta...
7.
Elksnis A, Welsh N, Wikstrom P, Lau J, Carlsson P
Free Radic Res
. 2023 Nov;
57(6-12):460-469.
PMID: 37972305
NADPH oxidase 4 (NOX4) inhibition has been reported to mitigate diabetes-induced beta-cell dysfunction and improve survival , as well as counteract high-fat diet-induced glucose intolerance in mice. We investigated the...
8.
Carlsson P, Espes D, Sisay S, Davies L, Smith C, Svahn M
Diabetologia
. 2023 May;
66(8):1431-1441.
PMID: 37221247
Aim/hypothesis: This study aimed to investigate the safety and efficacy of treatment with allogeneic Wharton's jelly-derived mesenchymal stromal cells (MSCs) in recent-onset type 1 diabetes. Methods: A combined Phase I/II...
9.
Cederblad L, Eklund G, Vedal A, Hill H, Caballero-Corbalan J, Hellman J, et al.
Diabetes Ther
. 2023 Apr;
14(6):953-965.
PMID: 37052842
Introduction: To improve the utilization of continuous- and flash glucose monitoring (CGM/FGM) data we have tested the hypothesis that a machine learning (ML) model can be trained to identify the...
10.
Shah P, Lueschen N, Ardestani A, Oberholzer J, Olerud J, Carlsson P, et al.
PLoS One
. 2023 Mar;
18(3):e0282771.
PMID: 36862649
[This corrects the article DOI: 10.1371/journal.pone.0161834.].